Successful prevention of virus acquisition may require a balance in antibody and CD4+ T cell responses in which changes in levels of virus-specific CCR5+ CD4+ T cells, preferential targets for HIV-1 infection (13), do not mute the effect of protective antibodies. Here, CCR5 is linked to HIV-1 infection.